MEDPAGE TODAY – Mar. 17, 2014 – A data analysis of more than
15,000 men diagnosed with prostate cancer showed that the 3,435 men whose first
or primary treatment was hormone blockade lived no longer compared to men who
chose watchful waiting, or monitoring. The results overturn a widely held
assumption that blocking male hormones would provide an advantage to men who
did not want to undergo surgery or radiation but wanted to do something more
than surveillance. The study results are in the Journal of Clinical Oncology.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment